ACRVVSBJDX• 12 Months (Normalized)
ACRV vs BJDX (Acrivon Therapeutics Inc. vs Bluejay Diagnostics Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
+9.68%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BJDX Performance $0.81
-86.72%
Bluejay Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+96.4%
ACRV outperforming by 96.40%
ACRVBJDX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BJDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ACRV Price | ACRV Gain (%) | BJDX Price | BJDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | +9.68% | $0.81 | -86.72% | +96.40% |
| Sep 15, 2026 | $1.83 | +18.06% | $0.85 | -86.14% | +104.20% |
| Sep 14, 2026 | $1.96 | +26.45% | $0.85 | -86.11% | +112.56% |
| Sep 11, 2026 | $2.00 | +29.03% | $0.90 | -85.34% | +114.37% |
| Sep 10, 2026 | $2.04 | +31.61% | $1.01 | -83.50% | +115.11% |
| Sep 09, 2026 | $1.99 | +28.39% | $1.01 | -83.50% | +111.89% |
| Sep 08, 2026 | $2.10 | +35.48% | $1.03 | -83.17% | +118.65% |
| Sep 04, 2026 | $2.13 | +37.42% | $0.83 | -86.41% | +123.83% |
| Sep 03, 2026 | $2.06 | +32.90% | $0.85 | -86.13% | +119.03% |
| Sep 02, 2026 | $2.15 | +38.71% | $0.85 | -86.13% | +124.84% |
| Sep 01, 2026 | $2.07 | +33.55% | $0.85 | -86.14% | +119.69% |
| Aug 31, 2026 | $2.09 | +34.84% | $0.87 | -85.78% | +120.62% |
| Aug 28, 2026 | $2.06 | +32.90% | $0.90 | -85.29% | +118.19% |
| Aug 27, 2026 | $2.15 | +38.71% | $0.91 | -85.13% | +123.84% |
| Aug 26, 2026 | $2.08 | +34.19% | $0.89 | -85.41% | +119.60% |
Page 1 of 17